10.1% Below Target

The Clorox Company (CLX) has a consensus 12-month price target of $105.5, implying 10.1% upside from $95.8. The 28 analysts covering CLX see moderate appreciation potential.

CLX has a consensus rating of "Hold" based on 28 Wall Street analysts. The rating breakdown is leaning bearish, with 6 Sell/Strong Sell ratings. The consensus 12-month price target of $105.5 implies 10.1% upside from current levels.

With a forward P/E of 17.309x, CLX trades at a relatively low valuation. The consensus target of $105.5 implies 10.1% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $139 for CLX, while the most conservative target is $83. The consensus of $105.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $114 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

CLX is heavily covered by Wall Street, with 28 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 18 recommend Hold, and 6 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month CLX stock forecast based on 28 Wall Street analysts shows a consensus price target of $105.5, with estimates ranging from $83 (bear case) to $139 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $87, with bear/bull scenarios of $55/$114.

Our quantitative valuation model calculates CLX's fair value at $87 (base case), with a bear case of $55 and bull case of $114. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 52/100.

CLX trades at a forward P/E ratio of 17.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 14.7x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are optimistic on CLX, with a "Hold" consensus rating and $105.5 price target (10.1% upside). 4 of 28 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

CLX analyst price targets range from $83 to $139, a 53% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $105.5 consensus represents the middle ground. Our model's $55-$114 range provides an independent fundamental perspective.